These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12566093)
1. Ethanol consumption decreases the synthesis of the mannose 6-phosphate/insulin-like growth factor II receptor but does not decrease its messenger RNA. Haorah J; MacDonald RG; Stoner JA; Donohue TM Biochem Pharmacol; 2003 Feb; 65(4):637-48. PubMed ID: 12566093 [TBL] [Abstract][Full Text] [Related]
2. Chronic ethanol administration decreases the ligand binding properties and the cellular content of the mannose 6-phosphate/insulin-like growth factor II receptor in rat hepatocytes. Haorah J; McVicker DL; Byrd JC; MacDonald RG; Donohue TM Biochem Pharmacol; 2002 Apr; 63(7):1229-39. PubMed ID: 11960599 [TBL] [Abstract][Full Text] [Related]
3. Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells. Greupink R; Bakker HI; van Goor H; de Borst MH; Beljaars L; Poelstra K Pharm Res; 2006 Aug; 23(8):1827-34. PubMed ID: 16850269 [TBL] [Abstract][Full Text] [Related]
4. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development. Hébert E Biosci Rep; 2006 Feb; 26(1):7-17. PubMed ID: 16779663 [TBL] [Abstract][Full Text] [Related]
5. Silencing the mannose 6-phosphate/IGF-II receptor differentially affects tumorigenic properties of normal breast epithelial cells. Caixeiro NJ; Martin JL; Scott CD Int J Cancer; 2013 Dec; 133(11):2542-50. PubMed ID: 23686499 [TBL] [Abstract][Full Text] [Related]
6. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells. Ghahary A; Tredget EE; Mi L; Yang L Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576 [TBL] [Abstract][Full Text] [Related]
7. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor. Mousavi SA; Fønhus MS; Kindberg GM; Tolleshaug H; Berg T Cell Biol Int; 2013 Jul; 37(7):703-12. PubMed ID: 23495048 [TBL] [Abstract][Full Text] [Related]
8. Upregulation and spatial shift in the localization of the mannose 6-phosphate/insulin-like growth factor II receptor during radiation enteropathy development in the rat. Wang J; Richter KK; Sung CC; Hauer-Jensen M Radiother Oncol; 1999 Feb; 50(2):205-13. PubMed ID: 10368045 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo. Lee JS; Weiss J; Martin JL; Scott CD Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693 [TBL] [Abstract][Full Text] [Related]
10. Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. de Bleser PJ; Jannes P; van Buul-Offers SC; Hoogerbrugge CM; van Schravendijk CF; Niki T; Rogiers V; van den Brande JL; Wisse E; Geerts A Hepatology; 1995 May; 21(5):1429-37. PubMed ID: 7737649 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-II/mannose 6-phosphate receptor is incapable of activating GTP-binding proteins in response to mannose 6-phosphate, but capable in response to insulin-like growth factor-II. Okamoto T; Nishimoto I; Murayama Y; Ohkuni Y; Ogata E Biochem Biophys Res Commun; 1990 May; 168(3):1201-10. PubMed ID: 2161218 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583 [TBL] [Abstract][Full Text] [Related]
13. Identification and in situ localization of the insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptor in the rat gastrointestinal tract: comparison with the IGF-I receptor. Heinz-Erian P; Kessler U; Funk B; Gais P; Kiess W Endocrinology; 1991 Oct; 129(4):1769-78. PubMed ID: 1655382 [TBL] [Abstract][Full Text] [Related]
14. Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains. Körner C; Nürnberg B; Uhde M; Braulke T J Biol Chem; 1995 Jan; 270(1):287-95. PubMed ID: 7814388 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor. Zavorka ME; Connelly CM; Grosely R; MacDonald RG Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor II/mannose 6-phosphate-receptor expression in liver and serum during acute CCl4 intoxication in the rat. De Bleser PJ; Scott CD; Niki T; Xu G; Wisse E; Geerts A Hepatology; 1996 Jun; 23(6):1530-7. PubMed ID: 8675174 [TBL] [Abstract][Full Text] [Related]
18. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767 [TBL] [Abstract][Full Text] [Related]
19. Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor. Prakash J; Beljaars L; Harapanahalli AK; Zeinstra-Smith M; de Jager-Krikken A; Hessing M; Steen H; Poelstra K Int J Cancer; 2010 Apr; 126(8):1966-1981. PubMed ID: 19795464 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8. Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]